Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
Riess H, Koppenhagen K, Tolle A, Kemkes-Matthes B, Gräve M, Patek F, Drexler M, Siemens HJ, Harenberg J, Weidinger G, Brom J, Haas S; TH-4 Study Group. Riess H, et al. Among authors: koppenhagen k. Thromb Haemost. 2003 Aug;90(2):252-9. doi: 10.1160/TH02-09-0061. Thromb Haemost. 2003. PMID: 12888872 Clinical Trial.
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.
Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J, Rektor I, Csányi A, Schneider D, Klingelhöfer J, Brom J, Weidinger G; PROTECT Trial Group. Diener HC, et al. Among authors: koppenhagen k. Stroke. 2006 Jan;37(1):139-44. doi: 10.1161/01.STR.0000195182.67656.ee. Epub 2005 Nov 23. Stroke. 2006. PMID: 16306456 Clinical Trial.
Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
Adolf J, Fritsche HM, Haas S, Hennig FF, Horbach T, Kastl S, Koppenhagen K, Michaelis HC, Rhamanzadeh R, Summa W, Wagner W, Weber U, Wolf H. Adolf J, et al. Among authors: koppenhagen k. Int Angiol. 1999 Jun;18(2):122-6. Int Angiol. 1999. PMID: 10424367 Clinical Trial.
Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
Kakkar VV, Boeckl O, Boneu B, Bordenave L, Brehm OA, Brücke P, Coccheri S, Cohen AT, Galland F, Haas S, Jarrige J, Koppenhagen K, LeQuerrec A, Parraguette E, Prandoni P, Roder JD, Roos M, Rüschemeyer C, Siewert JR, Vinazzer H, Wenzel E. Kakkar VV, et al. Among authors: koppenhagen k. World J Surg. 1997 Jan;21(1):2-8; discussion 8-9. doi: 10.1007/s002689900185. World J Surg. 1997. PMID: 8943170 Clinical Trial.
70 results